Results 31 to 40 of about 998,241 (312)

Inflammatory markers in COPD [PDF]

open access: yesThe Clinical Respiratory Journal, 2008
AbstractChronic obstructive pulmonary disease (COPD) is identified as an inflammatory disorder characterised by airway and lung inflammation and destruction with systemic involvement of multiple organ systems. The inflammatory reaction could be monitored not only in the airways by the use of bronchoalveolar lavage (BAL), sputum, exhaled air, and ...
openaire   +2 more sources

Biological markers of disease activity in inflammatory bowel diseases

open access: yes, 2023
Inflammatory bowel diseases (IBD) are chronic intestinal conditions of multifactorial aetiology including genetic susceptibility, immunological impairment, dysbiosis, and environmental factors.
Sylwia Szymanska   +3 more
core   +1 more source

EFFECT OF RESISTANCE TRAINING AND DETRAINING ON METABOLIC MARKERS

open access: yesJournal of Men's Health, 2019
Background and objective The aim of this study was to determine how resistance training and detraining later affected the growth factors, inflammatory markers, and bone metabolism markers in healthy male college students.
Jung-Kyu Kim   +2 more
doaj   +1 more source

Role of SH levels and markers of immune response in the stroke [PDF]

open access: yes, 2013
Background. Sulfhydryl groups (SH) are considered a key factor in redox sensitive reaction of plasma, and their modification could be considered an expression of abnormal generation of oxygen free radicals. Methods. Fifty consecutive patients with acute
Arru, Giannina   +26 more
core   +1 more source

Maternal inflammatory, lipid and metabolic markers and associations with birth and breastfeeding outcomes

open access: yesFrontiers in Nutrition, 2023
BackgroundConditions in utero influence intrauterine and postnatal infant growth and a few studies indicate that maternal inflammation and insulin resistance might affect birth and breastfeeding outcomes.
Sophie Hilario Christensen   +10 more
doaj   +1 more source

Myeloid IκBα deficiency promotes atherogenesis by enhancing leukocyte recruitment to the plaques. [PDF]

open access: yes, 2011
Activation of the transcription factor NF-κB appears to be involved in different stages of atherogenesis. In this paper we investigate the role of NF-κB inhibitor IκBα in atherosclerosis.
Menno P J de Winther   +53 more
core   +1 more source

The impact of adjuvant atorvastatin therapy on community-acquired pneumonia outcome: a prospective study of clinical and inflammatory responses in relation to mortality reduction

open access: yesThe Egyptian Journal of Bronchology, 2019
Introduction In treatment of pneumonia, new drugs besides antibiotics are investigated; especially statins with their anti-inflammatory, immunomodulatory, and antioxidant effects.
Yasser M. Mohamed   +3 more
doaj   +1 more source

Lifecourse social position and D-dimer; findings from the 1958 British birth cohort [PDF]

open access: yes, 2014
The aim is to examine the association of lifecourse socioeconomic position (SEP) on circulating levels of D-dimer. Data from the 1958 British birth cohort were used, social class was determined at three stages of respondents' life: at birth, at 23 and at
Lowe, Gordon   +30 more
core   +1 more source

Hematological Parameters and Inflammatory Markers in Children with Multisystem Inflammatory Syndrome

open access: yesGenel Tıp Dergisi, 2022
Objective: Multisystem inflammatory syndrome in children (MIS-C), is a newly recognised life-threatening complication of coronavirus disease 2019 (COVID-19).
Gülsüm Alkan   +3 more
doaj   +1 more source

Arginase and Procalcitonin: Promising Biomarkers for Early Diagnosis of Sepsis [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2020
Introduction: Sepsis remains a major cause of death in critically ill patients in Indian population because of high susceptibility towards infectious diseases in the world. Procalcitonin (PCT) is a well-studied marker in foreign countries but needs to
Shruti Rahul Mulgund   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy